AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 151 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $107,000 | +18.9% | 301,740 | +141.0% | 0.00% | – |
| Q1 2022 | $90,000 | -68.2% | 125,179 | +0.0% | 0.00% | -100.0% |
| Q4 2021 | $283,000 | -14.8% | 125,153 | +8.5% | 0.00% | 0.0% |
| Q3 2021 | $332,000 | -17.6% | 115,329 | +8.2% | 0.00% | 0.0% |
| Q2 2021 | $403,000 | +8.9% | 106,579 | -2.5% | 0.00% | 0.0% |
| Q1 2021 | $370,000 | +35.5% | 109,333 | +12.1% | 0.00% | 0.0% |
| Q4 2020 | $273,000 | +28.2% | 97,574 | +15.0% | 0.00% | – |
| Q3 2020 | $213,000 | -65.4% | 84,817 | +87.1% | 0.00% | -100.0% |
| Q2 2020 | $616,000 | +38.7% | 45,334 | -22.5% | 0.00% | 0.0% |
| Q1 2020 | $444,000 | +23.7% | 58,510 | +3.0% | 0.00% | 0.0% |
| Q4 2019 | $359,000 | +112.4% | 56,811 | +31.4% | 0.00% | – |
| Q3 2019 | $169,000 | -19.1% | 43,226 | 0.0% | 0.00% | – |
| Q2 2019 | $209,000 | -27.9% | 43,226 | +21.9% | 0.00% | -100.0% |
| Q1 2019 | $290,000 | +40.1% | 35,460 | -5.3% | 0.00% | 0.0% |
| Q4 2018 | $207,000 | +11.3% | 37,426 | +77.9% | 0.00% | – |
| Q3 2018 | $186,000 | -11.4% | 21,035 | 0.0% | 0.00% | – |
| Q2 2018 | $210,000 | +8.2% | 21,035 | +3.6% | 0.00% | – |
| Q1 2018 | $194,000 | -35.8% | 20,308 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $302,000 | -24.3% | 20,308 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $399,000 | +50.6% | 20,308 | +10.0% | 0.00% | 0.0% |
| Q2 2017 | $265,000 | +74.3% | 18,454 | +11.7% | 0.00% | – |
| Q1 2017 | $152,000 | -11.6% | 16,521 | 0.0% | 0.00% | – |
| Q4 2016 | $172,000 | +14.7% | 16,521 | 0.0% | 0.00% | – |
| Q3 2016 | $150,000 | +21.0% | 16,521 | 0.0% | 0.00% | – |
| Q2 2016 | $124,000 | +8.8% | 16,521 | +30.2% | 0.00% | – |
| Q1 2016 | $114,000 | -30.5% | 12,691 | 0.0% | 0.00% | – |
| Q4 2015 | $164,000 | +33.3% | 12,691 | 0.0% | 0.00% | – |
| Q3 2015 | $123,000 | -6.1% | 12,691 | 0.0% | 0.00% | – |
| Q2 2015 | $131,000 | – | 12,691 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |